Imaging and Diagnostic Workup for Suspected Nephrolithiasis

Imaging Strategy

• Ultrasound should be performed first in all patients with suspected kidney stones; it provides approximately 45 % sensitivity and 94 % specificity for ureteral stones and 88 % specificity for renal stones, and it must not delay emergency care in unstable patients. – European Association of Urology 1, 2, 3

• Non‑contrast computed tomography (CT) is the standard second‑line modality when ultrasound is inconclusive or detailed anatomic information is required; low‑dose protocols achieve about 93 % sensitivity and 97 % specificity while preserving diagnostic accuracy and minimizing radiation exposure. – European Association of Urology; American College of Radiology 1, 2, 3, 4

• Plain kidney‑ureter‑bladder (KUB) radiography can be used to differentiate radio‑opaque from radiolucent stones; its sensitivity for stone detection ranges from 44 % to 77 % and it is most useful for follow‑up imaging rather than primary diagnosis. – European Association of Urology 1, 2

Laboratory Evaluation

• Immediate dipstick urinalysis is recommended for all patients to detect hematuria, assess urine pH, identify signs of infection, and reveal crystals. – European Association of Urology 1, 2, 3

• A basic serum chemistry panel (creatinine, uric acid, ionized calcium, sodium, potassium, complete blood count, and C‑reactive protein) should be obtained to uncover metabolic abnormalities and evaluate for complications such as acute kidney injury or infection. – European Association of Urology 1, 2, 3

• C‑reactive protein and coagulation studies may be omitted when no interventional procedure is planned. – European Association of Urology 1, 2, 3

• Urine culture is indicated when urinalysis suggests infection or when the patient has a history of recurrent urinary tract infections, to guide management of infection‑related stones. – European Association of Urology 1, 2

Stone Analysis

• Stone compositional analysis should be performed for every first‑time stone former when material is available, as the results direct preventive therapy and help identify underlying metabolic disorders. – European Association of Urology 1, 2, 3

Special Populations

• Pregnant patients: use ultrasound as the first‑line imaging modality, magnetic resonance imaging (MRI) as the second line, and reserve low‑dose CT for situations where the other modalities are insufficient, thereby minimizing fetal radiation exposure. – European Association of Urology 1, 2, 3

• Children: ultrasound is strongly recommended as the initial study; if inadequate, proceed with KUB radiography or low‑dose non‑contrast CT. A thorough history should include family history of stone disease, hearing loss, and metabolic disorders. – American College of Radiology; European Association of Urology 5, 6, 1, 2, 3

• Genetic testing is advised for patients ≤ 25 years, those with suspected inherited disorders, recurrent stones (≥ 2 episodes), bilateral disease, or a strong family history; testing should be combined with metabolic evaluation and preceded by genetic counseling. – European Association of Urology 1, 2, 3

Critical Red‑Flag Situations

• Fever or signs of infection with urinary obstruction mandates urgent decompression. – European Association of Urology 1, 2, 3

• Obstruction in a solitary kidney requires immediate evaluation. – European Association of Urology 1, 2, 3

• Bilateral obstruction or anuria constitute emergencies demanding prompt intervention. – European Association of Urology 1, 2, 3

Common Pitfalls to Avoid

• Do not use contrast‑enhanced CT as a first‑line study; contrast obscures stones in the collecting system and offers no diagnostic advantage over non‑contrast CT. – American College of Radiology 4

• Do not assume resolution of hematuria after treating presumed non‑stone causes without repeat urinalysis; confirmation is required. – American Urological Association 7

Diagnostic Approach for Suspected Kidney Stones

Diagnostic Imaging

• The European Association of Urology recommends ultrasound as the primary diagnostic tool for suspected kidney stones, with 45% sensitivity and 94% specificity for ureteral stones and 88% specificity for renal stones 8
• If ultrasound is inconclusive or additional information is needed, non-contrast CT scan should be performed as the standard second-line imaging for acute flank pain, with low-dose CT maintaining high diagnostic accuracy (93.1% sensitivity, 96.6% specificity) while reducing radiation exposure 8
• Plain kidney-ureter-bladder (KUB) radiography can help differentiate between radioopaque and radiolucent stone types and is useful for follow-up 8

Laboratory Evaluation

• Urinalysis with both dipstick and microscopic evaluation should assess urine pH, presence of blood, signs of infection, and crystal identification to determine stone type 9
• A basic serum chemistry panel should include electrolytes, calcium, creatinine, uric acid, and blood cell count, with C-reactive protein added if infection is suspected 9
• Urine culture is recommended if urinalysis suggests infection or if the patient has a history of recurrent UTIs 9

Pain Management

• The European Urology guidelines recommend NSAIDs as the first-line treatment for renal colic, preferably diclofenac 75 mg intramuscularly, due to their effectiveness and reduced need for additional analgesia compared to opioids 10
• Opioids should be considered as second-choice analgesics when NSAIDs are contraindicated, with pain control maintained for at least six hours 10

Criteria for Immediate Referral/Admission

• Patients with fever, signs of infection, intractable pain, solitary kidney, bilateral obstruction, or acute kidney injury should be referred immediately 10

Metabolic Evaluation

• The American Urological Association recommends a comprehensive metabolic evaluation with 24-hour urine collection for high-risk first-time stone formers, all recurrent stone formers, and patients with bilateral or multiple stones, analyzing total urine volume, urine pH, calcium, oxalate, uric acid, citrate, sodium, potassium, and creatinine 9

Stone Analysis

• Stone analysis should be performed for all first-time stone formers when stone material is available, with patients instructed to strain their urine to catch any passed stones for analysis 8
• Repeat stone analysis is justified in patients not responding to treatment, as stone composition may change over time 9

Special Considerations

• For pregnant women, ultrasound is strongly recommended as first-line imaging, followed by MRI as second-line, and low-dose CT only as a last resort, according to the European Urology guidelines 8
• Genetic testing should be considered for patients with early-onset stone disease, suspected inherited disorders, recurrent stones, bilateral disease, or strong family history, as recommended by the European Urology guidelines 11

Follow-up

• Patients managed at home should be instructed to drink plenty of fluids, strain urine to catch any passed stones, and contact the doctor if pain worsens or new symptoms develop, with a follow-up phone call made one hour after initial assessment and analgesia administration 10

Investigation and Management of Suspected Renal Lithiasis

Imaging Strategy

• First‑line imaging should be renal ultrasonography for every patient with suspected renal colic, providing approximately 45 % sensitivity and 94 % specificity for ureteral stones and 88 % specificity for renal stones; it must not delay emergency care in unstable patients. 12
• If ultrasonography is nondiagnostic or clinical suspicion remains high, a non‑contrast computed tomography (CT) scan is the gold‑standard, with sensitivity of 93–97 % and specificity of 96.6 %. 12
• Low‑dose non‑contrast CT protocols preserve diagnostic accuracy (≈93.1 % sensitivity, 96.6 % specificity) while reducing radiation exposure. 12
• Non‑contrast CT outperforms intravenous urography, achieving 94–98 % sensitivity versus 52–59 % for urography. 13
• Plain abdominal radiography (KUB) may be employed to distinguish radiopaque from radiolucent stones, with sensitivity ranging from 44 % to 77 %; it is more valuable for follow‑up than for initial diagnosis. 12

Laboratory Evaluation

• Perform a bedside dipstick urinalysis in all patients to detect hematuria, assess pH, identify infection, and reveal crystals. 12
• Order a basic serum biochemistry panel (creatinine, uric acid, ionized calcium, sodium, potassium, complete blood count, and C‑reactive protein) to uncover metabolic abnormalities and assess for acute kidney injury or infection. 12
• C‑reactive protein and coagulation studies can be omitted when no interventional procedure is planned. 12
• Obtain a urine culture when the dipstick suggests infection or when the patient has a history of recurrent urinary‑tract infections, to guide antimicrobial therapy. 12

Stone Composition Analysis

• Analyze the composition of any retrieved stone from a first‑time episode (when material is available) because the results direct preventive therapy and help identify underlying metabolic disorders. 12

Special Populations

• Pregnant patients: use ultrasonography as the initial modality, magnetic resonance imaging as the second line, and reserve low‑dose CT only when the other studies are insufficient, thereby minimizing fetal radiation exposure. 12
• Children: begin with ultrasonography; if inadequate, proceed with KUB radiography or low‑dose non‑contrast CT. [14][12]
• Patients ≤ 25 years, those with suspected hereditary stone disease, ≥ 2 prior stone episodes, bilateral disease, or a strong family history should be offered genetic testing to detect inheritable metabolic disorders. 12

Urgent Management (Red‑Flag Situations)

• Fever or signs of infection combined with urinary obstruction require immediate decompression (percutaneous nephrostomy or ureteral stent). 12
• Obstruction in a solitary kidney mandates prompt evaluation, and bilateral obstruction or anuria constitute emergencies demanding immediate intervention. 12
• Collect urine for culture before and after decompression, start empiric antibiotics immediately, and adjust the regimen based on culture results. 12
• Definitive stone treatment should be postponed until sepsis is resolved. 12

Avoidable Pitfalls

• Do not use intravenous urography as a first‑line study; non‑contrast CT provides superior sensitivity. [13][14]
• Avoid contrast‑enhanced CT for initial stone assessment; reserve contrast studies for characterization of renal masses identified on ultrasonography. 13

Imaging and Management Guidelines for Suspected Kidney Stones

Initial Imaging Strategy

• The American College of Radiology recommends renal ultrasonography as the first‑line imaging test for all patients with suspected nephrolithiasis; it yields roughly 45 % sensitivity and 94 % specificity for ureteral stones and 88 % specificity for renal stones, reliably identifies hydronephrosis, and detects large stones (>5 mm) with nearly 100 % sensitivity. 15

• The American College of Radiology states that low‑dose non‑contrast CT of the abdomen and pelvis is the reference standard when ultrasound is inconclusive or detailed anatomy is required, providing 93–97 % sensitivity and 96.6 % specificity for stone detection. 16

• Low‑dose CT protocols preserve diagnostic performance (approximately 93 % sensitivity and 96.6 % specificity) while markedly lowering radiation exposure compared with conventional CT scans. 17

• Non‑contrast CT accurately measures stone size and location, information that guides management because stones smaller than 5 mm usually pass spontaneously. 17

Special Populations

Pregnancy

• For pregnant patients, the American College of Radiology advises using ultrasound as the initial modality, MRI as the second‑line option, and reserving low‑dose CT only when the other studies are insufficient, thereby minimizing fetal radiation exposure. 18

• Physiologic hydronephrosis is present in more than 80 % of pregnant individuals (predominantly on the right side) and can confound ultrasound interpretation. 18

Pediatrics

• In pediatric patients, the American College of Radiology recommends obtaining a detailed family history that includes stone disease, hearing loss, and metabolic disorders to identify potential hereditary contributors to nephrolithiasis. 16